FMC Corporation
FMC
$17.22
+2.44%
FMC Corporation is a pure-play global crop protection company operating in the Agricultural Inputs industry. It is one of the five largest patented crop protection firms, focusing on a balanced product portfolio and innovation in biologicals through its R&D pipeline.
FMC
FMC Corporation
$17.22
Related headlines
Investment Opinion: Should I buy FMC Today?
Based on a synthesis of the available data, the objective assessment for FMC is a Hold for speculative investors, Sell for risk-averse investors. The stock is not suitable for a traditional 'Buy' rating due to its deeply troubled fundamentals, including massive losses and high debt. However, the extreme valuation discount (PS of 0.50) and recent positive price momentum create a speculative opportunity for investors with a very high risk tolerance who are betting on a takeover or a sharp cyclical recovery. Most investors should avoid or reduce exposure until there is concrete evidence of a financial turnaround.
Sign up to view all
FMC 12-Month Price Forecast
The outlook is bifurcated between a speculative rebound story and a fundamental value trap. The high probability base case reflects ongoing struggles, but the significant bull case probability acknowledges the stock's potential for a sharp, news-driven rally from deeply oversold levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FMC Corporation's 12-month outlook, with a consensus price target around $22.39 and implied upside of +30.0% versus the current price.
Average Target
$22.39
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$14 - $22
Analyst target range
Analyst consensus data for target price and ratings distribution is not available in the provided inputs. The data includes recent rating actions from five firms, with a mix of 'Neutral', 'Sector Perform/Equal Weight', one 'Outperform', and one 'Underweight'. No sufficient analyst coverage data (e.g., consensus target price) is available for a comprehensive summary.
Bulls vs Bears: FMC Investment Factors
FMC presents a classic high-risk, high-potential-reward scenario. The stock is deeply discounted after a severe decline, with recent momentum driven by speculation. However, this is contrasted by alarming fundamental deterioration, including massive losses and high debt, which pose a substantial threat to the recovery thesis.
Bullish
- Significant Price Recovery: Stock up 24.2% over 3 months, rebounding from 52-week low.
- Deeply Discounted Valuation: Price-to-Sales ratio of 0.50 suggests a major discount to sales.
- Strong Market Position: One of the five largest patented crop protection companies globally.
- Positive Forward P/E: Forward P/E of 7.67 indicates market expects a return to profitability.
Bearish
- Severe Financial Deterioration: Q4 2025 net loss of $1.72B, negative net margin of -151.4%.
- High Financial Leverage: Debt-to-equity ratio of 2.03 indicates elevated financial risk.
- Negative Cash Flow: Trailing twelve-month free cash flow is negative $80.2 million.
- Poor Profitability Metrics: Deeply negative ROE (-108.1%) and minimal ROA (1.41%).
FMC Technical Analysis
Overall Assessment: The stock has experienced a severe downtrend over the past six months, with a price decline of 45.2%, but has shown a significant short-term rebound. The 52-week range is $12.17 to $44.78, indicating the current price of $17.22 is near the lower end of this spectrum, having recovered from the low. Short-term Performance: Over the last month, the stock has rallied strongly, gaining 16.8%, significantly outperforming the S&P 500, which fell 5.25%. The three-month performance is also positive, with a gain of 24.2%, again strongly outperforming the market's 4.6% decline. Current Position: The current price of $17.22 is approximately 61.5% below its 52-week high, highlighting the extent of the prior decline. It is, however, about 41.5% above its 52-week low, suggesting a recent recovery from the trough. Technical indicators like RSI are not provided in the data.
Beta
0.65
0.65x market volatility
Max Drawdown
-72.6%
Largest decline past year
52-Week Range
$12-$45
Price range past year
Annual Return
-59.2%
Cumulative gain past year
| Period | FMC Return | S&P 500 |
|---|---|---|
| 1m | +16.8% | -5.3% |
| 3m | +24.2% | -4.6% |
| 6m | -45.2% | -2.8% |
| 1y | -59.2% | +15.9% |
| ytd | +20.1% | -4.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FMC Fundamental Analysis
Revenue & Profitability: The company's most recent quarterly revenue (Q4 2025) was $1.14 billion, representing a year-over-year decline of 7.2%. Profitability has deteriorated sharply, with a net loss of $1.72 billion for the quarter, resulting in a deeply negative net margin of -151.4%. The trailing twelve-month free cash flow is also negative at -$80.2 million. Financial Health: The debt-to-equity ratio is elevated at 2.03, indicating a high level of financial leverage. The current ratio of 1.32 suggests the company has sufficient short-term liquidity to cover its immediate obligations. Operational Efficiency: Return on Equity (ROE) is deeply negative at -108.1%, reflecting the significant net losses. Return on Assets (ROA) is a minimal 1.41%, indicating poor efficiency in generating profits from its asset base.
Quarterly Revenue
$1.1B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.42%
Latest Quarter
Free Cash Flow
$-80200001.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FMC Overvalued?
Valuation Level: Given the company reported a significant net loss (Net Income < 0), the Price-to-Sales (PS) ratio is a more appropriate valuation metric. The current PS ratio is 0.50, based on a market cap of approximately $1.74 billion. This suggests the market is valuing the company at a significant discount relative to its sales. Peer Comparison: Industry average valuation metrics are not provided in the data for a direct comparison. The forward P/E ratio of 7.67 is noted but should be viewed with caution given the current unprofitability and reliance on future earnings estimates.
PE
-0.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -726x~107x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-63.2x
Enterprise Value Multiple
Investment Risk Disclosure
FMC's risk profile is elevated, primarily driven by fundamental financial weakness. The company's high debt-to-equity ratio of 2.03 creates significant financial leverage risk, especially in a high-interest-rate environment, as evidenced by substantial interest expenses. Operational risks are severe, with a net margin of -151.4% in the latest quarter and negative free cash flow, indicating the business is currently destroying value. The sharp revenue decline of 7.2% YoY suggests competitive or market demand headwinds in the agricultural inputs sector.
Market and sentiment risks are also pronounced. The stock's 45% decline over six months and extreme volatility, including a single-day crash from ~$30 to ~$15 in late October 2025, reflect deep investor skepticism. Recent news highlights that the rally is fueled by temporary factors like fertilizer price spikes and buyout speculation, not a turnaround in core operations. The lack of a clear analyst consensus and mixed ratings (Neutral, Underweight, Outperform) further underscores the uncertainty and high-risk nature of the investment.
FAQ
The key risks are severe financial deterioration, including ongoing net losses and negative free cash flow. The high debt-to-equity ratio of 2.03 creates leverage risk, especially if interest rates remain elevated. Operational risks include declining revenue and poor asset efficiency (ROA of 1.41%). Finally, the recent stock rally is attributed to speculation, not improved fundamentals, creating a risk of a sharp pullback.
The 12-month outlook is highly uncertain. The base case (50% probability) sees the stock trading between $15 and $25 as it struggles with debt and profitability. A bull case (25%) driven by a takeover or sharp recovery could push it toward $30-$44. A bear case (25%) involving further financial decline could see a retest of the $12-$15 range near its 52-week low.
Based on sales, FMC appears significantly undervalued with a PS ratio of 0.50, trading far below its 52-week high of $44.78. However, this discount is justified by terrible profitability metrics, including a negative net margin and ROE of -108.1%. The forward P/E of 7.67 suggests the market is pricing in a recovery, but given the current losses, the stock could be fairly valued or even risky at current levels.
FMC is not a good stock to buy for most investors seeking stability and growth. While the stock appears cheap with a Price-to-Sales ratio of 0.50, it carries extreme risk due to a massive Q4 2025 net loss of $1.72 billion, negative cash flow, and high debt. It may only suit highly speculative investors betting on a takeover or dramatic turnaround, which is far from certain.
FMC is unsuitable for a traditional long-term buy-and-hold strategy due to its fundamental challenges. It may be considered only for a very high-risk, short-to-medium-term speculative trade based on event-driven catalysts like M&A rumors or a cyclical uptick in fertilizer prices. Any investment should be closely monitored, as the company's financial health is precarious.
